| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GSE180563
|
SRA Run Selector
|
Juan Carlos Oliveros
|
Feb 04, 2022
|
|||||
| GSM5464789 |
Infected (deltaE) - 2dpi - Rep1 [E2A RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464790 |
Infected (deltaE) - 2dpi - Rep2 [E2C RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464791 |
Infected (deltaE) - 2dpi - Rep3 [E2D RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464792 |
Infected (deltaE) - 4dpi - Rep1 [E4A RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464793 |
Infected (deltaE) - 4dpi - Rep2 [E4B RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464794 |
Infected (deltaE) - 4dpi - Rep3 [E4D RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464795 |
Mock - 2dpi - Rep1 [M2A RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464796 |
Mock - 2dpi - Rep2 [M2B RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464797 |
Mock - 4dpi - Rep1 [M4A RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464798 |
Mock - 4dpi - Rep2 [M4B RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464799 |
Infected (Wild Type) - 2dpi - Rep1 [W2B RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464800 |
Infected (Wild Type) - 2dpi - Rep2 [W2C RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464801 |
Infected (Wild Type) - 2dpi - Rep3 [W2E RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464802 |
Infected (Wild Type) - 4dpi - Rep1 [W4A RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464803 |
Infected (Wild Type) - 4dpi - Rep2 [W4C RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 | ||
| GSM5464804 |
Infected (Wild Type) - 4dpi - Rep3 [W4D RNA-seq]
|
SRA | 1 |
|
|
Juan Carlos Oliveros | Feb 04, 2022 |
